nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—Abdominal bloating—Metformin—polycystic ovary syndrome	0.0382	0.0918	CcSEcCtD
Moclobemide—CYP2C19—urine—polycystic ovary syndrome	0.0371	0.116	CbGeAlD
Moclobemide—Appetite absent—Metformin—polycystic ovary syndrome	0.0365	0.0878	CcSEcCtD
Moclobemide—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.0345	0.0831	CcSEcCtD
Moclobemide—CYP1A2—urine—polycystic ovary syndrome	0.0303	0.0947	CbGeAlD
Moclobemide—CYP2C9—urine—polycystic ovary syndrome	0.0287	0.0899	CbGeAlD
Moclobemide—Heartburn—Metformin—polycystic ovary syndrome	0.0264	0.0635	CcSEcCtD
Moclobemide—CYP2D6—urine—polycystic ovary syndrome	0.0216	0.0675	CbGeAlD
Moclobemide—MAOB—embryo—polycystic ovary syndrome	0.0137	0.043	CbGeAlD
Moclobemide—Migraine—Metformin—polycystic ovary syndrome	0.013	0.0312	CcSEcCtD
Moclobemide—MAOA—embryo—polycystic ovary syndrome	0.0117	0.0367	CbGeAlD
Moclobemide—Abdominal distension—Metformin—polycystic ovary syndrome	0.0115	0.0276	CcSEcCtD
Moclobemide—MAOB—adrenal cortex—polycystic ovary syndrome	0.0113	0.0353	CbGeAlD
Moclobemide—Angina pectoris—Metformin—polycystic ovary syndrome	0.0111	0.0267	CcSEcCtD
Moclobemide—Drowsiness—Metformin—polycystic ovary syndrome	0.0102	0.0244	CcSEcCtD
Moclobemide—MAOB—endometrium—polycystic ovary syndrome	0.0101	0.0315	CbGeAlD
Moclobemide—MAOA—adrenal cortex—polycystic ovary syndrome	0.00961	0.0301	CbGeAlD
Moclobemide—Bradycardia—Metformin—polycystic ovary syndrome	0.00929	0.0223	CcSEcCtD
Moclobemide—MAOB—uterus—polycystic ovary syndrome	0.00927	0.029	CbGeAlD
Moclobemide—MAOB—pituitary gland—polycystic ovary syndrome	0.0091	0.0285	CbGeAlD
Moclobemide—MAOB—adipose tissue—polycystic ovary syndrome	0.00906	0.0284	CbGeAlD
Moclobemide—MAOA—endometrium—polycystic ovary syndrome	0.00858	0.0269	CbGeAlD
Moclobemide—Flushing—Metformin—polycystic ovary syndrome	0.00847	0.0204	CcSEcCtD
Moclobemide—MAOB—adrenal gland—polycystic ovary syndrome	0.00813	0.0254	CbGeAlD
Moclobemide—Bezafibrate—PPARG—polycystic ovary syndrome	0.00809	0.473	CrCbGaD
Moclobemide—MAOA—uterus—polycystic ovary syndrome	0.00791	0.0247	CbGeAlD
Moclobemide—Flatulence—Metformin—polycystic ovary syndrome	0.00782	0.0188	CcSEcCtD
Moclobemide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00778	0.0187	CcSEcCtD
Moclobemide—MAOA—pituitary gland—polycystic ovary syndrome	0.00776	0.0243	CbGeAlD
Moclobemide—MAOA—adipose tissue—polycystic ovary syndrome	0.00773	0.0242	CbGeAlD
Moclobemide—MAOB—female gonad—polycystic ovary syndrome	0.00758	0.0237	CbGeAlD
Moclobemide—MAOB—vagina—polycystic ovary syndrome	0.00753	0.0236	CbGeAlD
Moclobemide—Vision blurred—Metformin—polycystic ovary syndrome	0.00748	0.018	CcSEcCtD
Moclobemide—Tremor—Metformin—polycystic ovary syndrome	0.00744	0.0179	CcSEcCtD
Moclobemide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00737	0.0177	CcSEcCtD
Moclobemide—Malaise—Metformin—polycystic ovary syndrome	0.00716	0.0172	CcSEcCtD
Moclobemide—Syncope—Metformin—polycystic ovary syndrome	0.00712	0.0171	CcSEcCtD
Moclobemide—MAOB—endocrine gland—polycystic ovary syndrome	0.00705	0.0221	CbGeAlD
Moclobemide—Palpitations—Metformin—polycystic ovary syndrome	0.00702	0.0169	CcSEcCtD
Moclobemide—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00698	0.0168	CcSEcCtD
Moclobemide—MAOA—adrenal gland—polycystic ovary syndrome	0.00694	0.0217	CbGeAlD
Moclobemide—Hypertension—Metformin—polycystic ovary syndrome	0.00686	0.0165	CcSEcCtD
Moclobemide—Chest pain—Metformin—polycystic ovary syndrome	0.00676	0.0163	CcSEcCtD
Moclobemide—Myalgia—Metformin—polycystic ovary syndrome	0.00676	0.0163	CcSEcCtD
Moclobemide—Discomfort—Metformin—polycystic ovary syndrome	0.00668	0.0161	CcSEcCtD
Moclobemide—CYP2C19—vagina—polycystic ovary syndrome	0.00657	0.0206	CbGeAlD
Moclobemide—MAOA—female gonad—polycystic ovary syndrome	0.00647	0.0202	CbGeAlD
Moclobemide—MAOA—vagina—polycystic ovary syndrome	0.00643	0.0201	CbGeAlD
Moclobemide—Shock—Metformin—polycystic ovary syndrome	0.00638	0.0153	CcSEcCtD
Moclobemide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00626	0.0151	CcSEcCtD
Moclobemide—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00614	0.0192	CbGeAlD
Moclobemide—Hypotension—Metformin—polycystic ovary syndrome	0.00606	0.0146	CcSEcCtD
Moclobemide—MAOA—endocrine gland—polycystic ovary syndrome	0.00601	0.0188	CbGeAlD
Moclobemide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0059	0.0142	CcSEcCtD
Moclobemide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00582	0.014	CcSEcCtD
Moclobemide—Dyspnoea—Metformin—polycystic ovary syndrome	0.00578	0.0139	CcSEcCtD
Moclobemide—Somnolence—Metformin—polycystic ovary syndrome	0.00576	0.0139	CcSEcCtD
Moclobemide—Dyspepsia—Metformin—polycystic ovary syndrome	0.0057	0.0137	CcSEcCtD
Moclobemide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00563	0.0135	CcSEcCtD
Moclobemide—Fatigue—Metformin—polycystic ovary syndrome	0.00559	0.0134	CcSEcCtD
Moclobemide—Constipation—Metformin—polycystic ovary syndrome	0.00554	0.0133	CcSEcCtD
Moclobemide—Bezafibrate—CYP1A1—polycystic ovary syndrome	0.00546	0.32	CrCbGaD
Moclobemide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00534	0.0128	CcSEcCtD
Moclobemide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0053	0.0127	CcSEcCtD
Moclobemide—Urticaria—Metformin—polycystic ovary syndrome	0.00515	0.0124	CcSEcCtD
Moclobemide—Abdominal pain—Metformin—polycystic ovary syndrome	0.00512	0.0123	CcSEcCtD
Moclobemide—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00502	0.0157	CbGeAlD
Moclobemide—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00476	0.0149	CbGeAlD
Moclobemide—Asthenia—Metformin—polycystic ovary syndrome	0.00465	0.0112	CcSEcCtD
Moclobemide—Pruritus—Metformin—polycystic ovary syndrome	0.00458	0.011	CcSEcCtD
Moclobemide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00443	0.0107	CcSEcCtD
Moclobemide—Dizziness—Metformin—polycystic ovary syndrome	0.00429	0.0103	CcSEcCtD
Moclobemide—Vomiting—Metformin—polycystic ovary syndrome	0.00412	0.00991	CcSEcCtD
Moclobemide—Rash—Metformin—polycystic ovary syndrome	0.00409	0.00983	CcSEcCtD
Moclobemide—Dermatitis—Metformin—polycystic ovary syndrome	0.00408	0.00982	CcSEcCtD
Moclobemide—Headache—Metformin—polycystic ovary syndrome	0.00406	0.00976	CcSEcCtD
Moclobemide—Nausea—Metformin—polycystic ovary syndrome	0.00385	0.00926	CcSEcCtD
Moclobemide—CYP2D6—female gonad—polycystic ovary syndrome	0.00384	0.012	CbGeAlD
Moclobemide—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00357	0.0112	CbGeAlD
Moclobemide—Haloperidol—CYP1A1—polycystic ovary syndrome	0.00354	0.207	CrCbGaD
Moclobemide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000364	0.00147	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—LHB—polycystic ovary syndrome	0.000358	0.00145	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000353	0.00143	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—HSD3B2—polycystic ovary syndrome	0.00035	0.00141	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000348	0.00141	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000348	0.00141	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000348	0.0014	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000343	0.00138	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000341	0.00137	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKR1C1—polycystic ovary syndrome	0.000339	0.00137	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000325	0.00131	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000323	0.0013	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000322	0.0013	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PNPLA2—polycystic ovary syndrome	0.00032	0.00129	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00032	0.00129	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000317	0.00128	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000317	0.00128	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000317	0.00128	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—SULT2A1—polycystic ovary syndrome	0.000312	0.00126	CbGpPWpGaD
Moclobemide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000311	0.00126	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00031	0.00125	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000308	0.00124	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000304	0.00123	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SRD5A1—polycystic ovary syndrome	0.000304	0.00123	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—RRM2—polycystic ovary syndrome	0.000302	0.00122	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000298	0.0012	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000294	0.00119	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—YAP1—polycystic ovary syndrome	0.000291	0.00118	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—STAR—polycystic ovary syndrome	0.00029	0.00117	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000285	0.00115	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000281	0.00113	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000281	0.00113	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—NAMPT—polycystic ovary syndrome	0.00028	0.00113	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP11A1—polycystic ovary syndrome	0.000276	0.00112	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000275	0.00111	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000271	0.0011	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000265	0.00107	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000262	0.00106	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000262	0.00106	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKR1C3—polycystic ovary syndrome	0.000261	0.00105	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000259	0.00105	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—HMMR—polycystic ovary syndrome	0.000258	0.00104	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000258	0.00104	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP17A1—polycystic ovary syndrome	0.000257	0.00104	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000256	0.00103	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000252	0.00102	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.00025	0.00101	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—HSD3B1—polycystic ovary syndrome	0.000246	0.000995	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00024	0.000969	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000239	0.000964	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000239	0.000964	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000233	0.000942	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.00023	0.000929	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.000229	0.000924	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.000229	0.000924	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000228	0.000921	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000226	0.000912	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—LHB—polycystic ovary syndrome	0.000225	0.000907	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—TH—polycystic ovary syndrome	0.000222	0.000897	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000222	0.000895	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—HSD3B2—polycystic ovary syndrome	0.00022	0.000886	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000219	0.000883	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000218	0.000879	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—SLC2A4—polycystic ovary syndrome	0.000216	0.000873	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.000213	0.000859	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000213	0.000859	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000213	0.000859	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.000212	0.000857	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000211	0.00085	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000211	0.00085	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000211	0.00085	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000209	0.000843	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000209	0.000843	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000208	0.00084	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000206	0.000832	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000204	0.000824	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP19A1—polycystic ovary syndrome	0.000203	0.000821	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000196	0.00079	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SULT2A1—polycystic ovary syndrome	0.000196	0.00079	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000195	0.000788	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000195	0.000787	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000194	0.000784	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000194	0.000783	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000193	0.000781	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00019	0.000766	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—RRM2—polycystic ovary syndrome	0.00019	0.000765	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000186	0.000751	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000184	0.000744	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—YAP1—polycystic ovary syndrome	0.000183	0.000738	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000182	0.000734	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GNAS—polycystic ovary syndrome	0.000181	0.000732	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000181	0.000731	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000181	0.000731	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000178	0.00072	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000178	0.00072	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000177	0.000715	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000176	0.000711	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NAMPT—polycystic ovary syndrome	0.000176	0.000709	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000174	0.000702	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP11A1—polycystic ovary syndrome	0.000173	0.0007	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—NCOR1—polycystic ovary syndrome	0.000173	0.000698	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000171	0.000692	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000168	0.000678	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000166	0.000672	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000166	0.000672	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000166	0.000669	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000165	0.000667	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000165	0.000666	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000165	0.000666	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP1A1—polycystic ovary syndrome	0.000164	0.000661	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000164	0.000661	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000162	0.000654	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000161	0.000651	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000159	0.000641	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000156	0.000631	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—MTHFR—polycystic ovary syndrome	0.000153	0.000617	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000152	0.000612	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000151	0.000611	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000144	0.00058	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000144	0.00058	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000141	0.000569	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000141	0.000569	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000139	0.000563	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—TH—polycystic ovary syndrome	0.000139	0.000563	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000138	0.000558	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000137	0.000554	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000136	0.000548	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000136	0.000547	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000136	0.000547	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000133	0.000539	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000132	0.000534	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000131	0.000529	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000128	0.000515	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000126	0.000509	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.000125	0.000505	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PPARG—polycystic ovary syndrome	0.000124	0.0005	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000124	0.000499	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000122	0.000493	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—POMC—polycystic ovary syndrome	0.000122	0.000493	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—INS—polycystic ovary syndrome	0.000121	0.00049	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000118	0.000477	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000117	0.000471	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000115	0.000465	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GNAS—polycystic ovary syndrome	0.000114	0.00046	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000112	0.000454	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000112	0.000452	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	0.000111	0.00045	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000109	0.000441	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NCOR1—polycystic ovary syndrome	0.000108	0.000438	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000107	0.000433	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000107	0.000431	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000106	0.000429	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	0.000106	0.000429	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000106	0.000426	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000105	0.000424	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000104	0.00042	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP1A1—polycystic ovary syndrome	0.000103	0.000415	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000101	0.000406	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.96e-05	0.000402	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	9.78e-05	0.000395	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	9.7e-05	0.000391	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—MTHFR—polycystic ovary syndrome	9.58e-05	0.000387	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	9.56e-05	0.000386	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	9.52e-05	0.000385	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	9.48e-05	0.000383	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	9.26e-05	0.000374	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	9.26e-05	0.000374	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	9.18e-05	0.000371	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	9.09e-05	0.000367	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.98e-05	0.000363	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	8.97e-05	0.000362	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	8.65e-05	0.000349	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	8.52e-05	0.000344	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.51e-05	0.000344	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	8.45e-05	0.000341	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	8.31e-05	0.000335	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	8.29e-05	0.000335	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.26e-05	0.000333	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	8.25e-05	0.000333	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	8.21e-05	0.000331	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	8.18e-05	0.00033	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.15e-05	0.000329	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	8.1e-05	0.000327	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	7.95e-05	0.000321	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	7.89e-05	0.000318	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	7.84e-05	0.000317	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PPARG—polycystic ovary syndrome	7.77e-05	0.000314	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	7.75e-05	0.000313	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—POMC—polycystic ovary syndrome	7.67e-05	0.000309	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	7.64e-05	0.000309	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	7.63e-05	0.000308	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—INS—polycystic ovary syndrome	7.62e-05	0.000308	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	7.58e-05	0.000306	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	7.55e-05	0.000305	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.53e-05	0.000304	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	7.48e-05	0.000302	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.43e-05	0.0003	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	7.22e-05	0.000291	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	7.13e-05	0.000288	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	7.07e-05	0.000285	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	7.02e-05	0.000283	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	6.99e-05	0.000282	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	6.96e-05	0.000281	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	6.74e-05	0.000272	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TH—polycystic ovary syndrome	6.6e-05	0.000266	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	6.47e-05	0.000261	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.44e-05	0.00026	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	6.42e-05	0.000259	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	6.39e-05	0.000258	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.35e-05	0.000256	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TH—polycystic ovary syndrome	6.07e-05	0.000245	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	6.04e-05	0.000244	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	6.04e-05	0.000244	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TH—polycystic ovary syndrome	6.02e-05	0.000243	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	5.94e-05	0.00024	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	5.91e-05	0.000238	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	5.86e-05	0.000236	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	5.55e-05	0.000224	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	5.5e-05	0.000222	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	5.39e-05	0.000218	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TH—polycystic ovary syndrome	5.14e-05	0.000208	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	5.13e-05	0.000207	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	5e-05	0.000202	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	4.96e-05	0.0002	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	4.91e-05	0.000198	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	4.87e-05	0.000196	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	4.72e-05	0.000191	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	4.7e-05	0.00019	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	4.68e-05	0.000189	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	4.54e-05	0.000183	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	4.48e-05	0.000181	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	4.44e-05	0.000179	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	4.2e-05	0.00017	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	4.17e-05	0.000168	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	4.14e-05	0.000167	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	4e-05	0.000161	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.79e-05	0.000153	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	3.68e-05	0.000149	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	3.63e-05	0.000146	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—INS—polycystic ovary syndrome	3.61e-05	0.000146	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	3.54e-05	0.000143	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	3.38e-05	0.000137	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	3.35e-05	0.000135	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.34e-05	0.000135	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.32e-05	0.000134	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	3.31e-05	0.000134	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—INS—polycystic ovary syndrome	3.29e-05	0.000133	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	2.87e-05	0.000116	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	2.83e-05	0.000114	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—INS—polycystic ovary syndrome	2.81e-05	0.000113	CbGpPWpGaD
